{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:07:22Z","timestamp":1785294442441,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Beijing Province","award":["7172096"],"award-info":[{"award-number":["7172096"]}]},{"name":"Beijing Chinese Medicine Science and Technology Development Fund Project Foundation","award":["JJ-2020-46"],"award-info":[{"award-number":["JJ-2020-46"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98641-5","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:16:02Z","timestamp":1745248562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adjusted glycated albumin is a novel indicator of glycemic control in patients with macroalbuminuria in diabetic kidney disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Jin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Hou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"98641_CR1","doi-asserted-by":"publisher","first-page":"2315607","DOI":"10.1155\/2020\/2315607","volume":"2020","author":"XX Zhang","year":"2020","unstructured":"Zhang, X. X., Kong, J. & Yun, K. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: A Meta-Analysis of observational studies. J. Diabetes Res. 2020, 2315607 (2020).","journal-title":"J. Diabetes Res."},{"key":"98641_CR2","doi-asserted-by":"crossref","unstructured":"Johansen, K. et al. US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am. J. kidney diseases: official J. Natl. Kidney Foundation. 81, A8\u2013A11.  (2023).","DOI":"10.1053\/j.ajkd.2022.12.001"},{"key":"98641_CR3","doi-asserted-by":"crossref","unstructured":"Mohandes, S. et al. Molecular pathways that drive diabetic kidney disease. J. Clin. Investig. 133(4). (2023).","DOI":"10.1172\/JCI165654"},{"key":"98641_CR4","doi-asserted-by":"crossref","unstructured":"Liew, A. et al. Asian Pacific society of nephrology clinical practice guideline on diabetic kidney disease. Nephrol. (Carlton Vic) 12\u201345. (2020).","DOI":"10.1111\/nep.13785"},{"issue":"4","key":"98641_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10408363.2017.1299684","volume":"54","author":"S Yazdanpanah","year":"2017","unstructured":"Yazdanpanah, S. et al. Evaluation of glycated albumin (GA) and GA\/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review. Crit. Rev. Clin. Lab. Sci. 54 (4), 219\u2013232 (2017).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"3","key":"98641_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ekir.2017.11.009","volume":"3","author":"T Gan","year":"2018","unstructured":"Gan, T., Liu, X. & Xu, G. Glycated albumin versus HbA1c in the evaluation of glycemic control in patients with diabetes and CKD. Kidney Int. Rep. 3 (3), 542\u2013554 (2018).","journal-title":"Kidney Int. Rep."},{"issue":"1","key":"98641_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000511614","volume":"145","author":"T Bomholt","year":"2021","unstructured":"Bomholt, T. et al. The use of HbA1c, glycated albumin and continuous glucose monitoring to assess glucose control in the chronic kidney disease population including Dialysis. Nephron 145 (1), 14\u201319 (2021).","journal-title":"Nephron"},{"issue":"5","key":"98641_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","volume":"41","author":"RJ Galindo","year":"2020","unstructured":"Galindo, R. J., Beck, R. W., Scioscia, M. F., Umpierrez, G. E. & Tuttle, K. R. Glycemic monitoring and management in advanced chronic kidney disease. Endocr. Rev. 41 (5), 756\u2013774 (2020).","journal-title":"Endocr. Rev."},{"issue":"12","key":"98641_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41574-020-00425-6","volume":"16","author":"KR Klein","year":"2020","unstructured":"Klein, K. R. & Buse, J. B. The trials and tribulations of determining HbA1c targets for diabetes mellitus. Nat. Rev. Endocrinol. 16 (12), 717\u2013730 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"98641_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.7326\/M20-5938","volume":"174","author":"SD Navaneethan","year":"2021","unstructured":"Navaneethan, S. D. et al. Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline. Ann. Intern. Med. 174 (3), 385\u2013394 (2021).","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"98641_CR11","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.2337\/dci21-0035","volume":"44","author":"E Selvin","year":"2021","unstructured":"Selvin, E. & Hemoglobin A(1c)-Using epidemiology to guide medical practice: Kelly West award lecture 2020. Diabetes Care. 44 (10), 2197\u20132204 (2021).","journal-title":"Diabetes Care"},{"issue":"4","key":"98641_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ekir.2023.01.040","volume":"8","author":"P Wijewickrama","year":"2023","unstructured":"Wijewickrama, P. et al. Narrative review of glycemic management in people with diabetes on peritoneal Dialysis. Kidney Int. Rep. 8 (4), 700\u2013714 (2023).","journal-title":"Kidney Int. Rep."},{"issue":"1","key":"98641_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00592-020-01581-x","volume":"58","author":"S Copur","year":"2021","unstructured":"Copur, S. et al. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker. Acta Diabetol. 58 (1), 81\u201391 (2021).","journal-title":"Acta Diabetol."},{"issue":"2","key":"98641_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"P Soeters","year":"2019","unstructured":"Soeters, P., Wolfe, R., Shenkin, A. Hypoalbuminemia: Pathogenesis and clinical significance. JPEN J. Parenter. Enter. Nutr. 43 (2), 181\u2013193 (2019).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"98641_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/bs.pmbts.2019.01.006","volume":"162","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Xing, G. & Zhang, L. Glycated albumin level is significantly decreased in patients suffering nephrotic syndrome. Prog. Mol. Biol. Transl. Sci. 162, 307\u2013319 (2019).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"Pt 4","key":"98641_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/0004563214568162","volume":"52","author":"K Fukami","year":"2015","unstructured":"Fukami, K. et al. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. Ann. Clin. Biochem. 52 (Pt 4), 488\u2013496 (2015).","journal-title":"Ann. Clin. Biochem."},{"issue":"02","key":"98641_CR17","first-page":"110","volume":"41","author":"YSX Fei","year":"2018","unstructured":"Fei, Y. S. X., Chen, T. F., Fan, Y., Cheng, D. S. & Wang, N. S. The value of glycated albumin in assessing blood glucose in diabetic nephropathy patients with massive proteinuria after correction. Shanghai Med. J. 41 (02), 110\u2013114 (2018).","journal-title":"Shanghai Med. J."},{"issue":"7","key":"98641_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"K Alberti","year":"1998","unstructured":"Alberti, K. & Zimmet, P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Medicine: J. Br. Diabet. Association. 15 (7), 539\u2013553 (1998).","journal-title":"Diabet. Medicine: J. Br. Diabet. Association"},{"issue":"11","key":"98641_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"P Stevens","year":"2013","unstructured":"Stevens, P. & Levin, A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158 (11), 825\u2013830 (2013).","journal-title":"Ann. Intern. Med."},{"issue":"03","key":"98641_CR20","first-page":"255","volume":"37","author":"Section PoEotCMAN","year":"2021","unstructured":"Section PoEotCMAN. Clinical practice guidelines for diabetic kidney disease in China. Chin. J. Nephrol. 37 (03), 255\u2013304 (2021).","journal-title":"Chin. J. Nephrol."},{"issue":"9","key":"98641_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"A Levey","year":"2009","unstructured":"Levey, A. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (9), 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"98641_CR22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"C Wilkinson","year":"2003","unstructured":"Wilkinson, C. et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110 (9), 1677\u20131682 (2003).","journal-title":"Ophthalmology"},{"issue":"1","key":"98641_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1753-0407.12940","volume":"12","author":"Chinese Diabetes Society of Chinese Medical Association ESoCMA","year":"2020","unstructured":"Chinese Diabetes Society of Chinese Medical Association ESoCMA. Expert consensus on glycated hemoglobin targets and achievement strategies for Chinese adults with type 2 diabetes. Chin. J. Diabetes. 12 (1), 1\u201312 (2020).","journal-title":"Chin. J. Diabetes"},{"issue":"6","key":"98641_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1177\/193229681100500619","volume":"5","author":"T Kohzuma","year":"2011","unstructured":"Kohzuma, T., Yamamoto, T., Uematsu, Y., Shihabi, Z. & Freedman, B. Basic performance of an enzymatic method for glycated albumin and reference range determination. J. Diabetes Sci. Technol. 5 (6), 1455\u20131462 (2011).","journal-title":"J. Diabetes Sci. Technol."},{"issue":"05","key":"98641_CR25","first-page":"458","volume":"47","author":"XXLS Liu","year":"2022","unstructured":"Liu, X. X. L. S. et al. Establishment of a correction model for estimating average blood glucose based on HbA1c in diabetes patients with renal insufficiency. Med. J. Chin. PLA. 47 (05), 458\u2013463 (2022).","journal-title":"Med. J. Chin. PLA"},{"issue":"3","key":"98641_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12020-016-1091-6","volume":"55","author":"E Dozio","year":"2017","unstructured":"Dozio, E., Di Gaetano, N., Findeisen, P. & Corsi Romanelli, M. M. Glycated albumin: from biochemistry and laboratory medicine to clinical practice. Endocrine 55 (3), 682\u2013690 (2017).","journal-title":"Endocrine"},{"issue":"2","key":"98641_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","volume":"3","author":"A Stirban","year":"2014","unstructured":"Stirban, A., Gawlowski, T. & Roden, M. Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol. Metab. 3 (2), 94\u2013108 (2014).","journal-title":"Mol. Metab."},{"key":"98641_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cca.2013.06.011","volume":"424","author":"T Kitamura","year":"2013","unstructured":"Kitamura, T. et al. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing\u2019s syndrome. Clin. Chim. Acta. 424, 164\u2013167 (2013).","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"98641_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diabres.2008.04.012","volume":"81","author":"M Koga","year":"2008","unstructured":"Koga, M., Kasayama, S., Kanehara, H. & Bando, Y. CLD (chronic liver diseases)-HbA1C as a suitable indicator for Estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res. Clin. Pract. 81 (2), 258\u2013262 (2008).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"98641_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2009.01.013","volume":"84","author":"M Koga","year":"2009","unstructured":"Koga, M., Murai, J., Saito, H., Matsumoto, S. & Kasayama, S. Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res. Clin. Pract. 84 (2), 163\u2013167 (2009).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"98641_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2018.05.044","volume":"484","author":"H Xingxing","year":"2018","unstructured":"Xingxing, H. et al. Associations of body mass index with glycated albumin and glycated albumin\/glycated hemoglobin A 1c ratio in Chinese diabetic and non-diabetic populations. Clin. Chim. Acta. 484, 117\u2013121 (2018).","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"98641_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00592-009-0168-6","volume":"47","author":"M Koga","year":"2010","unstructured":"Koga, M., Murai, J., Saito, H., Mukai, M. & Kasayama, S. Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men. Acta Diabetol. 47 (2), 173\u2013177 (2010).","journal-title":"Acta Diabetol."},{"issue":"11","key":"98641_CR33","doi-asserted-by":"publisher","first-page":"e51098","DOI":"10.1371\/journal.pone.0051098","volume":"7","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance. PloS One 7 (11), e51098 (2012).","journal-title":"PloS One"},{"key":"98641_CR34","doi-asserted-by":"crossref","unstructured":"Roohk, H. V., Zaidi, A. R. & Patel, D. Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation. Inflamm. Res. (2017).","DOI":"10.1007\/s00011-017-1089-4"},{"issue":"2","key":"98641_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00592-008-0072-5","volume":"46","author":"M Koga","year":"2009","unstructured":"Koga, M., Saito, H., Mukai, M., Otsuki, M. & Kasayama, S. Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetol. 46 (2), 141\u2013144 (2009).","journal-title":"Acta Diabetol."},{"key":"98641_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.diabres.2017.05.020","volume":"130","author":"T Yajima","year":"2017","unstructured":"Yajima, T., Yajima, K., Hayashi, M., Takahashi, H. & Yasuda, K. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in type 2 diabetes mellitus patients with short duration of Hemodialysis. Diabetes Res. Clin. Pract. 130, 148\u2013153 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"98641_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2169\/internalmedicine.50.4129","volume":"50","author":"T Okada","year":"2011","unstructured":"Okada, T. et al. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern. Med. 50 (1), 23\u201329 (2011).","journal-title":"Intern. Med."},{"issue":"12","key":"98641_CR38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/1753-0407.12823","volume":"10","author":"W Rathmann","year":"2018","unstructured":"Rathmann, W., Bongaerts, B. & Kostev, K. Association of characteristics of people with type 2 diabetes mellitus with discordant values of fasting glucose and HbA1c. J. Diabetes. 10 (12), 934\u2013941 (2018).","journal-title":"J. Diabetes"},{"key":"98641_CR39","doi-asserted-by":"crossref","unstructured":"Giglio, R. et al. Recent updates and advances in the use of glycated albumin for the diagnosis and monitoring of diabetes and renal, Cerebro- and Cardio-Metabolic diseases. J. Clin. Med. 9(11). (2020).","DOI":"10.3390\/jcm9113634"},{"issue":"03","key":"98641_CR40","first-page":"207","volume":"16","author":"JSDJ Zhou","year":"2015","unstructured":"Zhou, J. S. D. J. et al. Clinical study on the effect of urine protein on glycated albumin in diabetic nephropathy patients. Chin. J. Integr. Med. Nephrol. 16 (03), 207\u2013210 (2015).","journal-title":"Chin. J. Integr. Med. Nephrol."},{"key":"98641_CR41","unstructured":"Jialal, V. G. R. V. I. Hypoalbuminemia. (StatPearls Publishing, 2020)."},{"key":"98641_CR42","unstructured":"Rector\u2019s, B. THE KIDNEY. Canada: Elsevier. 978\u2009\u2013\u200996 ."},{"key":"98641_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/nu13082746","volume":"13","author":"E Enuwosa","year":"2021","unstructured":"Enuwosa, E., Gautam, L., King, L. & Chichger, H. Saccharin and sucralose protect the glomerular microvasculature in vitro against VEGF-Induced permeability. Nutrients 13, 8 (2021).","journal-title":"Nutrients"},{"key":"98641_CR44","doi-asserted-by":"publisher","first-page":"101920","DOI":"10.1016\/j.redox.2021.101920","volume":"42","author":"N Rabbani","year":"2021","unstructured":"Rabbani, N. & Thornalley, P. Protein glycation - biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine. Redox Biol. 42, 101920 (2021).","journal-title":"Redox Biol."},{"issue":"1","key":"98641_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF01788898","volume":"30","author":"L Bent-Hansen","year":"1987","unstructured":"Bent-Hansen, L., Feldt-Rasmussen, B., Kverneland, A. & Deckert, T. Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30 (1), 2\u20134 (1987).","journal-title":"Diabetologia"},{"issue":"3","key":"98641_CR46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10047-019-01097-4","volume":"22","author":"S Ueda","year":"2019","unstructured":"Ueda, S. et al. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing Hemodialysis. J. Artif. Organs: Official J. Japanese Soc. Artif. Organs. 22 (3), 264\u2013267 (2019).","journal-title":"J. Artif. Organs: Official J. Japanese Soc. Artif. Organs"},{"issue":"7","key":"98641_CR47","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1515\/cclm-2022-0105","volume":"60","author":"FC Chume","year":"2022","unstructured":"Chume, F. C., Freitas, P. A. C., Schiavenin, L. G., Pimentel, A. L. & Camargo, J. L. Glycated albumin in diabetes mellitus: a meta-analysis of diagnostic test accuracy. Clin. Chem. Lab. Med. 60 (7), 961\u2013974 (2022).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"98641_CR48","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jdiacomp.2016.02.021","volume":"30","author":"T Yajima","year":"2016","unstructured":"Yajima, T. et al. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on Hemodialysis. J. Diabetes Complications. 30 (5), 786\u2013789 (2016).","journal-title":"J. Diabetes Complications"},{"issue":"1","key":"98641_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ajh.27158","volume":"99","author":"JT Prchal","year":"2024","unstructured":"Prchal, J. T. & Lichtman, M. A. Measurement of red cell, plasma, and blood volume: A perspective. Am. J. Hematol. 99 (1), 9\u201311 (2024).","journal-title":"Am. J. Hematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98641-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:16:10Z","timestamp":1757160970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98641-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98641"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98641-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was in accordance with Declaration of Helsinki. The research scheme was reviewed and approved by the medical ethics committee of Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University, the reference number 2017BL02-047-02.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"13812"}}